Ebola Vaccine Trials Start in Liberia
After West Africans suffered from nearly 22,000 infections and 9,000 casualties, physicians began large-scale human testing of two potential Ebola vaccines on Monday.

After West Africans suffered from nearly 22,000 infections and 9,000 casualties, physicians began large-scale human testing of two potential Ebola vaccines on Monday.

World Health Organization (WHO) statistics show a significant drop in cases of Ebola in Guinea, Liberia, and even beleaguered Sierra Leone, indicating a potential–though not guaranteed–end of an outbreak that has taken thousands of lives and affected millions.

Fort Hood, Texas, has received its first eighty-seven Ebola warriors who have returned home after helping to fight the deadly disease in Liberia. Most of the soldiers are members who are permanently assigned to Fort Hood, but some are from Fort Carson, Colorado. The soldiers now begin a twenty-one day monitoring period to ensure none of them returned carrying the deadly virus.

While it has mostly disappeared from mainstream media headlines in the United States, the Ebola outbreak in West Africa appears to be no nearer to an end. Liberia, a nation that had proclaimed near-victory against the virus, reported a resurgence of cases near its border with Sierra Leone, but pushed on with a ban on cremation triggered by public demand.

Since it was first identified as a threat in March of this year, the Ebola outbreak in West Africa has taken at least 7,500, according to the latest tally by the World Health Organization.

Nearly nine months, 6,915 deaths, and 18,603 cases later, the United Nations is ready to take some action on the Ebola outbreak ravaging West Africa. Secretary-General Ban Ki-Moon announced a tour of the stricken West African countries—Sierra Leone, Liberia, and
